OrthoPediatrics Corp.

49 articles with OrthoPediatrics Corp.

• OrthoPediatrics Corp. to Sponsor Two Medical Meetings in September 2020

  9/9/2020

  OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced its continued support for the Scoliosis Research Society, including the Company’s Gold Level sponsorship for the 55th Annual Meeting & Course taking place virtually on September 9-13.

• OrthoPediatrics Corp. to Participate in the Morgan Stanley 18th Annual Global Healthcare Conference

  9/8/2020

  OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Mark Throdahl, Chief Executive Officer, Fred Hite, Chief Operating Officer and Chief Financial Officer, and Dave Bailey, President, are scheduled to participate in the Morgan Stanley 18 th Annual Global Healthcare Conference on Tuesday, September 15, 2020. Event: M

• OrthoPediatrics Corp. Announces 1,000th Procedure Utilizing its Innovative Pediatric Nailing Platform | FEMUR (“PNP | FEMUR”) System, the First Pediatric-Specific Solution Optimized to Treat Fractures and Deformities

  9/3/2020

  OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced completion of the 1,000th surgery utilizing its Pediatric Nailing Platform | FEMUR, the first system specifically designed and developed to address the unique pediatric anatomies when treating femoral fractures and deformity correction procedures.

• OrthoPediatrics Corp. Maintains its Diamond Sponsorship for Virtual 30th Annual Baltimore Limb Deformity Course (“BLDC”)

  8/24/2020

  OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced its continued Diamond sponsorship for the virtual 30th Annual Baltimore Limb Deformity Course.

• OrthoPediatrics Corp. to Participate in the 5th Annual Needham Virtual Med Tech 1x1 Conference

  8/10/2020

  OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced that Mark Throdahl, Chief Executive Officer, Fred Hite, Chief Operating Officer and Chief Financial Officer, and Dave Bailey, President, are scheduled to participate in the 5th Annual Needham Virtual Med Tech 1x1 Conference.

• OrthoPediatrics Corp. Reports Second Quarter 2020 Financial Results

  8/5/2020

  OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for the second quarter ended June 30, 2020.

• OrthoPediatrics Corp. Achieves 500th Case with FIREFLY® Pedicle Screw Navigation GuidesCompany’s partnership with Mighty Oak Medical for 3D printed, patient-specific technology continues advancing pediatric scoliosis treatment

  8/3/2020

  OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced the 500th case performed with the FIREFLY® Pedicle Screw Navigation Guides technology in collaboration with Mighty Oak Medical.

• OrthoPediatrics Corp. to Report Second Quarter 2020 Financial Results on August 5, 2020Conference Call to Discuss Results on August 6, 2020 at 8:00 a.m. ET

  7/23/2020

  OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced that the Company is scheduled to release its second quarter 2020 financial results on Wednesday, August 5, 2020, after the market closes.

• OrthoPediatrics Corp. Announces Closing of Offering of Common Stock - June 22, 2020

  6/22/2020

  OrthoPediatrics Corp., a company exclusively focused on advancing the field of pediatric orthopedics, announced the closing of its underwritten public offering of 1,600,000 shares of its common stock at a price to the public of $47.00 per share.

• OrthoPediatrics Corp. Announces Pricing of Offering of Common Stock - June 18, 2020

  6/18/2020

  OrthoPediatrics Corp., a company exclusively focused on advancing the field of pediatric orthopedics, announced the pricing of its underwritten public offering of 1,600,000 shares of its common stock at a price to the public of $47.00 per share.

• OrthoPediatrics Corp. Announces Proposed Public Offering of Common Stock - June 17, 2020

  6/17/2020

  OrthoPediatrics Corp., a company exclusively focused on advancing the field of pediatric orthopedics, announced that it is commencing an underwritten public offering of its common stock.

• OrthoPediatrics Corp. Commences Initial U.S. Launch of ApiFix’s FDA-Approved Spinal Deformity Correction System

  6/10/2020

  ApiFix, the only posterior motion-preserving scoliosis correction technology available in the U.S., provides unique advantages for treating progressive adolescent idiopathic scoliosis

• OrthoPediatrics Corp. to Continue Sponsorship for 2020 POSNA Annual Meeting

  5/13/2020

  OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced the Company’s continued Double-Diamond sponsorship for the virtual 2020 Pediatric Orthopaedic Society of North America (“POSNA”) Annual Meeting, which will open online May 13, 2020 and remain available until December 31, 2020. OrthoPediatrics retains its designation as a Double Diamond S

• OrthoPediatrics Corp. Reports First Quarter 2020 Financial ResultsInitiates Senior Executive Succession Plan with Appointment of David Bailey as President and Fred Hite as Chief Operating Officer and Chief Financial Officer

  5/5/2020

  OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced its financial results for the first quarter ended March 31, 2020.

• OrthoPediatrics Corp. to Participate in the 6th Annual SunTrust Robinson Humphrey Life Sciences Summit

  4/29/2020

  OrthoPediatrics Corp. announced that Mark Throdahl, President & Chief Executive Officer, Fred Hite, Chief Financial Officer, and Dave Bailey, Executive Vice President, are scheduled to participate in the 6th Annual SunTrust Robinson Humphrey Life Sciences Summit Virtual Series.

• OrthoPediatrics Corp. to Report First Quarter 2020 Financial Results on May 5, 2020Conference Call to Discuss Results on May 6, 2020 at 8:00 a.m. ET

  4/21/2020

  OrthoPediatrics Corp. announced that the Company is scheduled to release its first quarter 2020 financial results on Tuesday, May 5, 2020, after the market closes.

• Trendlines Announces Acquisition of Portfolio Company ApiFix Ltd. by OrthoPediatrics Corp.

  4/2/2020

  ApiFix's FDA and CE Mark approved less invasive non-fusion surgical system for treating progressive adolescent idiopathic scoliosis to enter broad distribution   [02-April-2020]   MISGAV, Israel , April 2, 2020 /PRNewswire/ -- The Trendlines Group Ltd. ("Trendlines" or the "Company") is pleased to announce the 100% acquisition of portfolio company ApiFix Ltd. ("ApiFix"),

• OrthoPediatrics Corp. Announces Acquisition of ApiFix Ltd. with FDA-Approved Non-Fusion Scoliosis Technology

  4/1/2020

  Expands portfolio of spinal deformity systems with unique, less invasive, non-fusion surgical solution for progressive adolescent idiopathic scoliosis

• OrthoPediatrics Corp. Receives FDA 510(k) Clearance and Expanded Neuromuscular Indications for its RESPONSE™ Scoliosis System

  3/31/2020

  OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to expand the indications for its RESPONSE™ Scoliosis System to include neuromuscular implants.

• OrthoPediatrics Corp. Provides COVID-19 Business Update

  3/30/2020

  OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, provided a business update on the proactive steps it is taking in response to the global COVID-19 pandemic.